TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing...
TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive...
New ticker symbol, “FEED” will begin trading on the Nasdaq at the open of the market on December 12, 2025
ENvue® Feeding Tube Placement System Identified as Core Growth Platform Strategic Rebranding and Name Change to Reflect Company’s Focus on Multi-Billion-Dollar Enteral-Feeding...
Training platform accelerates onboarding, expands distribution potential and better positions Company for growth
NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that it has entered into a definitive...
Latest patent award strengthens competitive moat and reinforces leadership in medical navigation technology
Patent strengthens company’s leadership in feeding tube placement and opens path to broader vascular navigation market
Common Stock Will Begin Trading on Split-Adjusted Basis on August 12, 2025
Upfront $8 Million in Gross Proceeds and potential $40 million in Gross Proceeds from Exercise of Additional Investment Rights